RCKT
ROCKET PHARMACEUTICALS, INC.
+0.07 (+2.01%)3.55USD1.0M成交股數390M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 29.5M | 31.5M | 34.1M | 42.7M | 35.9M | 37.4M | 42.3M | 46.3M | 45.2M | 46.8M | 51.4M | 46.4M |
| 銷售管理費用 | 17.4M | 17.1M | 18.4M | 25.0M | 28.4M | 25.3M | 27.1M | 27.4M | 22.1M | 18.6M | 17.4M | 15.8M |
| 營業利益 | −46.9M-27% | −48.5M-23% | −52.2M-25% | −71.1M-3% | −64.4M-4% | −62.7M-4% | −69.4M+1% | −73.7M+19% | −67.4M | −65.4M | −68.8M | −62.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | 123M-301% | −47.6M-21% | −50.3M-25% | −68.9M-1% | −61.3M-1% | −60.3M-3% | −66.7M+2% | −69.6M+19% | −62.1M | −61.9M | −65.7M | −58.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | 1.08-293% | -0.42-32% | -0.45-37% | -0.62-16% | -0.56-15% | -0.62-17% | -0.71-13% | -0.74+1% | -0.66 | -0.75 | -0.82 | -0.73 |
| 稀釋股數 | 115M | 112M | 112M | 111M | 110M | 94.8M | 94.2M | 93.7M | 93.5M | 82.6M | 80.5M | 79.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 225M | 49.6M | 75.9M | 32.8M | 49.8M | 164M | 65.6M | 38.6M | 35.3M | 226M | 45.1M | 64.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 423M | 285M | 368M | 421M | 471M | 528M | 394M | 446M | 499M | 599M | 462M | 515M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 54.3M | 47.4M | 54.4M | 66.8M | 58.9M | 64.5M | 63.9M | 61.8M | 57.9M | 57.7M | 58.8M | 55.9M |
| 股東權益 | 369M | 238M | 314M | 354M | 412M | 463M | 330M | 385M | 442M | 541M | 403M | 459M |
| 負債比 | 12.8% | 16.6% | 14.8% | 15.9% | 12.5% | 12.2% | 16.2% | 13.8% | 11.6% | 9.6% | 12.7% | 10.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −45.4M | – | – | −55.8M-2% | – | – | – | −56.9M | – | – | −57.6M |
| 資本支出 | – | 93K | – | – | 364K | – | – | – | 2.0M | – | – | 3.0M |
| 自由現金流 | – | −45.5M | – | – | −56.2M-5% | – | – | – | −58.9M | – | – | −60.6M |
| 折舊攤銷 | 1.6M | 1.6M | 2.7M | 2.0M | 2.5M | 1.8M | 1.9M | 1.8M | 1.7M | 1.2M | 1.2M | 1.1M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | – | −223M | –% | -2.01 | −190M |
| FY2024 | 0.00 | – | −259M | –% | -2.73 | −216M |
| FY2023 | 0.00 | – | −246M | –% | -2.92 | −211M |
| FY2022 | 0.00 | – | −222M | –% | -3.26 | −187M |
| FY2021 | 0.00 | – | −169M | –% | -2.67 | −129M |
| FY2020 | 0.00 | – | −140M | –% | -2.52 | −95.2M |
| FY2019 | 0.00 | – | −77.3M | –% | -1.58 | −87.9M |
| FY2018 | 0.00 | – | −74.5M | –% | -1.89 | −55.2M |